改善严重精神疾病患者肺癌筛查的可及性
本文概述了严重精神疾病(包括精神分裂症和双相障碍)患者肺癌死亡率较高、筛查参与率低及多层面障碍,并描述了放射科与精神科试点合作以提高该人群肺癌筛查可及性的潜在作用。
要点
- 严重精神疾病患者肺癌死亡率是一般人群的2至4倍,部分与高吸烟率、诊断延迟和治疗不均有关。
- 符合条件患者肺癌筛查年参与率不足4%,严重精神疾病患者可能更低。
- 放射科与精神科试点合作可能改善严重精神疾病患者肺癌筛查的可及性。
核心结论
- 严重精神疾病患者肺癌筛查参与率低且存在多层面障碍,放射科与精神科试点合作可能改善其筛查可及性。
研究设计与样本
- 本文为概述当前肺癌筛查挑战并描述放射科与精神科试点合作的稿件。
临床应用与阅片要点
- 作者描述了放射科与精神科试点合作,认为其可能改善严重精神疾病患者肺癌筛查的可及性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Lung cancer continues to be the leading cause of cancer mortality in the United States across all races and ethnicities, but it does not affect everyone equally. Individuals with serious mental illness (SMI), including schizophrenia and bipolar disorder, experience two to four times greater lung cancer mortality in part due to high rates of smoking, delays in cancer diagnosis, and inequities in cancer treatment. Additionally, adults with SMI experience patient, clinician, and health care system-level barriers to accessing cancer screening, such as cognitive deficits that impact understanding of cancer risk, higher rates of poverty and social isolation, patient-provider communication challenges, decreased access to tobacco cessation, and the fragmentation of primary care and mental health care. Despite the proven benefits and mandated coverage by public and private payers, lung cancer screening participation rates remain low among eligible patients, below 4% a year. Given disparities in other cancer screening modalities, these rates are likely to be even lower among individuals with SMI. This article provides a brief overview of current challenges in lung cancer screening and describes a pilot collaboration between radiology and psychiatry that has potential to improve access to lung cancer screening for individuals with serious mental illness.
引用
- Flores EJ, Park ER, Irwin KE, et al. Improving Lung Cancer Screening Access for Individuals With Serious Mental Illness. J Am Coll Radiol. 2019. PMID: 30947893. doi:10.1016/j.jacr.2018.12.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。